Telemedicine Technologies provides at the provider’s convenience classic Secure Hosting or Health Data Hosting, in accordance with GDPR and European health data protection regulations.
The Health Data Hosting service is based on an Infrastructure including a Primary Site and a Secondary Site that are geographically distinct. The Primary Site is ISO 27001 certified.
This Infrastructure is provided by specialist companies selected by Telemedicine Technologies for their excellent performance.
The Infrastructure is equipped with a fire protection system.
The redundancy of the power systems allows a normal running of the infrastructure in case of a total power cut, without any interruption of the service.
At the client’s request, we can provide a mirror site that guarantees automatic and immediate copying of data, thus bypassing any blocking or hacking of data.
Daily saving of application data performed locally on the Primary Site and on the remote Secondary Site.
Service availability rate > 99.9%.
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
3 million +
patients
in database
50 000 +
users
worlwide
June 27, 2024
25 September 2024 from 4:00PM to 5:30PM (CEST) Webinar Overview It has been demonstrated that using standards from the start of clinical research studies (i.e. protocol and CRF development) can save significant time and resources and results in higher quality research. Unfortunately, it is not always clear how to select the appropriate standards for the […]
June 27, 2024
Applied Clinical Trials Online ACT: How can data management challenges be addressed? Specifically, is there any opportunity to address them with artificial intelligence (AI)? Lacroix: There is a lot of opportunity across the life cycle to assist with this and it’s interesting because historically it was always: we want to throw people at some of […]
June 27, 2024
Fiercebiotech Experts recommend that CGT manufacturers proactively design a comprehensive market access strategy early in clinical development and commercial planning timelines, ideally more than three years prior to launch. This strategy should focus on addressing the nuanced market access challenges for such treatments, including but not limited to, distribution network design, tailored commercial site engagement, […]